• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL TACTIFLEX¿ ABLATION CATHETER, SENSOR ENABLED¿; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL TACTIFLEX¿ ABLATION CATHETER, SENSOR ENABLED¿; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION Back to Search Results
Model Number A-TFSE-FJ
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Cardiac Perforation (2513)
Date of Event 12/18/2025
Type of Reportable Event Serious Injury
Event or Problem Description
During a ventricular tachycardia procedure, the patient experienced a cardiac tamponade which required a pericardiocentesis.While advancing the catheter into the left ventricle, a drop in blood pressure and poor contractility in the cardiac silhouette was observed.Fluoroscopy and an echocardiogram revealed a cardiac tamponade.A pericardiocentesis was performed to stabilize the patient.The perforation was located in the av groove.There was no performance issue with any abbott device.The physician is unsure what caused the tamponade.
 
Additional Manufacturer Narrative
Additional information: d9, g3, h2, h3, h6, h11.The results of the investigation are inconclusive since the device was not returned for analysis.The batch record was reviewed to ensure that each manufacturing and inspection operation was performed.Based on the information received, the cause of the reported incident could not be conclusively determined.Per the ifu, cardiac tamponade and pericardial effusion are known risks during the use of this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TACTIFLEX¿ ABLATION CATHETER, SENSOR ENABLED¿
Common Device Name
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
Manufacturer (Section D)
ABBOTT MEDICAL
parque industrial, zona franca coyol s.a.
edificio #44b, calle 0, avenida 2, coyol
alajuela, costa rica 1897- 4050
CS  1897-4050
Manufacturer (Section G)
ABBOTT MEDICAL
parque industrial, zona franca coyol s.a.
edificio #44b, calle 0, avenida 2, coyol
alajuela, costa rica 1897- 4050
CS   1897-4050
Manufacturer Contact
wendy mccarty
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key23896005
Report Number3008452825-2025-00691
Device Sequence Number11917060
Product Code OAE
UDI-Device Identifier05415067034618
UDI-Public(01)05415067034618(10)10719520(17)260131
Combination Product (Y/N)N
Initial Reporter CountrySP
PMA/510(K) Number
P220013
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 03/09/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date01/31/2026
Device Model NumberA-TFSE-FJ
Device Catalogue NumberA-TFSE-FJ
Device Lot Number10719520
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/18/2025
Supplement Date Received by Manufacturer02/25/2026
Initial Report FDA Received Date12/26/2025
Supplement Report FDA Received Date03/09/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured02/11/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Life Threatening; Required Intervention;
Patient SexUnknown
-
-